Personalized digital care in obstetrics: the impact of Heart4Mom® application in the detection and management of severe preeclampsia

Background. Preeclampsia, whether de novo or super­im­posed on chronic hypertension, is a major contributor to ma­ter­nal and perinatal morbidity and mortality world­wide. It affects approximately 5% of pregnancies, being closely as­so­cia­ted with fetal growth restriction (FGR), par­ti­cu­larly in early-onset cases. Early identification of high-risk fac­tors and timely intervention remain essential to improve out­comes. Case presentation. We report the case of a preg­nant patient with a history of severe pre­eclamp­sia and FGR in a previous pregnancy, requiring pre­term de­li­very at 27 weeks. In the current pregnancy, early-on­set FGR was diag­nosed at 26 weeks, despite ade­quate an­ti­hyper­ten­sive therapy. The patient was enrolled in a tele­mo­ni­to­­ring pro­gram (Heart4Mom®) from the first tri­mes­ter, ena­bling con­ti­nuous remote blood pressure sur­veil­lance. A hyper­ten­sive crisis (systolic BP ≥ 200 mmHg) was promptly detected through the app, prompting emergency re­fer­ral. Subsequent fetal Doppler evaluation revealed re­versed a-wave in the duc­tus venosus and reduced fetal move­ments, leading to ur­gent delivery. Management and outcomes. The case was managed in accordance with the Romanian Society of Obstetrics and Gynecology and the NICE guidelines. The integration of digital health tools facilitated real-time data collection, early diagnosis, multidisciplinary care, and post­par­tum psychological follow-up. This case is notable for de­mon­stra­ting the successful clinical management of early-on­set preeclampsia without maternal or fetal mortality – an out­come rarely reported in literature, especially in ca­ses diag­nosed prior to 26 weeks. Conclusions. This case high­lights the critical role of telemonitoring platforms, such as Heart4Mom®, in managing high-risk pregnancies. Re­mote sur­veil­lance enables the early detection of clinical de­te­rio­ra­tion, timely therapeutic intervention, and personalized care plan­ning. Future prospective studies are needed to validate these findings and to further integrate digital tools into stan­dard obstetric protocols for hypertensive disorders.